Clinical trials in Heerlen – page 7

Research focusing on multiple sclerosis and stroke management, including trials evaluating new therapeutic approaches for both relapsing and progressive forms of MS.

• MS Treatment Innovations
• Stroke Prevention Studies
• Cerebral Hemorrhage Management

Novel therapies being tested include frexalimab and tolebrutinib for multiple sclerosis patients.

Comprehensive studies in cancer treatment, with particular focus on lung cancer, melanoma, and prostate cancer therapies.

• Non-Small Cell Lung Cancer Treatments
• Advanced Melanoma Management
• Prostate Cancer Diagnostics

Innovative approaches including PSMA-PET/CT imaging and immunotherapy combinations are being evaluated.

Studies addressing cardiovascular diseases and related conditions, including innovative treatments for heart disease and stroke prevention.

• Major Cardiovascular Events Prevention
• Atrial Fibrillation Management
• Lipid-Lowering Therapies

Trials include pelacarsen for cardiovascular risk reduction and statin therapy evaluations.

Research into pulmonary conditions, particularly focusing on fibrotic lung diseases and their treatment approaches.

• Pulmonary Fibrosis Treatments
• Interstitial Lung Disease Studies
• Long-term Safety Evaluations

Including trials of inhaled treprostinil and nerandomilast for various forms of lung fibrosis.